FOR IMMEDIATE RELEASE
Recent Court Rulings in Mass Torts: Attorneys Adjusting Strategies in Wake of ‘Seminal’ Decisions
A spate of state and federal court rulings have attorneys for litigants in drug and medical device liability litigation – and mass tort litigation in general – studying new ways to move forward in the prosecution or defense of their claims. Learn what impact those decisions may have before you handle your next mass tort case.
NEW YORK – Aug. 17, 2017 – The law on key issues – such as jurisdiction and preemption – in some high-stakes cases have taken unanticipated and significant turns based on recent appellate court rulings that have attorneys for plaintiffs and corporations alike adjusting their respective strategies.
Two federal decisions by the U.S. Supreme Court, and one by the Third Circuit U.S. Court of Appeals, as well as two key state decisions by the New Jersey Appellate Division were handed down recently impacting our understanding of contemporary issues of jurisdiction, preemption and evidence.
Attorneys are invited to a 90-minute CLE-eligible webinar on the impact of these cases. Produced by HB Litigation Conferences, the program will take place at 2 p.m. Eastern on Sept. 18, 2017. To learn more and to register for the online event — titled Reversed & Remanded: The Impact of Recent Appellate Rulings on Mass Torts — click here: http://bit.ly/2uUewNU.
The challenges or opportunities these decisions present to attorneys form the basis of this webinar, developed by Judge Marina Corodemus (ret.), a leading national special master in complex litigation for both Federal and State Courts.
Judge Corodemus, who for a decade was the sole New Jersey Superior Court mass tort judge, was recently appointed by U.S. District Judge Robert Kugler to oversee the execution of the $300 million settlement of more than 2,000 cases brought by users of the hypertension drug Benicar.
The judge is also founder and chair of the highly regarded Mass Torts Judicial Forum with Hon. Marina Corodemus (ret.), which will be held on April 23, 2018, in New York. To learn more about that event click here: https://litigationconferences.com/mtjf2018/.
The webinar panelists – whom Judge Corodemus considers “mass tort attorneys at the top of the practice” – will come together for a live webcast from the JAMS Resolution Center in New York to discuss what she considers to be “seminal” decisions.
The speakers are:
Judge Marina Corodemus (ret.), Corodemus & Corodemus LLC and JAMS New York, chair and moderator
William J. Beausoleil, Hughes Hubbard & Reed LLP
Jeffrey S. Grand, Seeger Weiss LLP
Bruce D. Greenberg, Lite DePalma Greenberg, LLC
Heidi Levine, Sidley Austin LLP
Ellen Relkin, Weitz & Luxenberg, P.C.
Alan E. Rothman, Arnold & Porter Kaye Scholer LLP
Produced by HB Litigation Conferences, the program will be eligible for CLE. For more information, visit the HB website at http://bit.ly/2uUewNU.
HB Litigation Conferences is an independent provider of continuing legal education and content. www.LitigationConferences.com.
(484) 324-2755 x2120